Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
December 6, 2006
Flavivirus nonstructural protein NS1: complementary surprises
Jacob J Schlesinger
Virology
|
January 15, 2008
Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells
Ramil Sapinoro, Ketna Volcy, W W Shanaka I Rodrigo, et al.
Journal of Medical Virology
|
January 20, 2009
Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection
Maria T Arévalo, Patricia J Simpson-Haidaris, Zhihua Kou, et al.
Virology
|
June 4, 2014
Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-mediated antibody-dependent enhancement of infection
Nunya Chotiwan, John T Roehrig, Jacob J Schlesinger, et al.
Journal of Virology
|
September 29, 2006
Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32)
W W Shanaka I Rodrigo, Xia Jin, Shanley D Blackley, et al.
The American Journal of Tropical Medicine and Hygiene
|
January 15, 2009
An automated Dengue virus microneutralization plaque assay performed in human Fc{gamma} receptor-expressing CV-1 cells
W W Shanaka I Rodrigo, Danielle C Alcena, Robert C Rose, et al.
Journal of Virology
|
October 12, 2007
Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro
Shanley Blackley, Zhihua Kou, Huiyuan Chen, et al.
Journal of Virology
|
March 1, 2003
Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model
Thomas J Chambers, Yan Liang, Deborah A Droll, et al.
Vaccine
|
October 21, 2010
A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice
Olivia K T Block, W W Shanaka I Rodrigo, Matthew Quinn, et al.
Journal of Medical Virology
|
November 28, 2007
Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells
Zhihua Kou, Matthew Quinn, Huiyuan Chen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Proceedings of the National Academy of Sciences of the United States of America
|
December 6, 2006
Flavivirus nonstructural protein NS1: complementary surprises
Jacob J Schlesinger
Virology
|
January 15, 2008
Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells
Ramil Sapinoro, Ketna Volcy, W W Shanaka I Rodrigo, et al.
Journal of Medical Virology
|
January 20, 2009
Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection
Maria T Arévalo, Patricia J Simpson-Haidaris, Zhihua Kou, et al.
Virology
|
June 4, 2014
Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-mediated antibody-dependent enhancement of infection
Nunya Chotiwan, John T Roehrig, Jacob J Schlesinger, et al.
Journal of Virology
|
September 29, 2006
Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32)
W W Shanaka I Rodrigo, Xia Jin, Shanley D Blackley, et al.
The American Journal of Tropical Medicine and Hygiene
|
January 15, 2009
An automated Dengue virus microneutralization plaque assay performed in human Fc{gamma} receptor-expressing CV-1 cells
W W Shanaka I Rodrigo, Danielle C Alcena, Robert C Rose, et al.
Journal of Virology
|
October 12, 2007
Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro
Shanley Blackley, Zhihua Kou, Huiyuan Chen, et al.
Journal of Virology
|
March 1, 2003
Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model
Thomas J Chambers, Yan Liang, Deborah A Droll, et al.
Vaccine
|
October 21, 2010
A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice
Olivia K T Block, W W Shanaka I Rodrigo, Matthew Quinn, et al.
Journal of Medical Virology
|
November 28, 2007
Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells
Zhihua Kou, Matthew Quinn, Huiyuan Chen, et al.
Page
of 2